Press Coverage

Neurosurgeons identify malign tumors with Cellvizio optical biopsy

11 September 2015

A team of neurosurgeons in Germany has used the Cellvizio optical biopsy system to identify cancerous brain and spinal tumors in real time, suggesting that the technology could be used for immediate diagnosis in future operations to improve surgical outcomes and patient recovery.

Latest News

Mauna Kea Technologies announces results of its Combined General Meeting of June 5, 2025 

Mauna Kea Technologies announces results of its Combined General Meeting of June 5, 2025 

Mauna Kea Technologies Announces Major AI Breakthrough with Cellvizio in Pancreatic Cystic Lesion Risk Stratification 

Mauna Kea Technologies Announces Major AI Breakthrough with Cellvizio in Pancreatic Cystic Lesion Risk Stratification 

Mauna Kea Technologies Provides Update on Safeguard Proceedings, Strategic Discussions and Operational Progress 

Mauna Kea Technologies Provides Update on Safeguard Proceedings, Strategic Discussions and Operational Progress 

No results found.